HK$7.29
0.97%
Hong Kong, Oct 23, 04:00 pm HKT. Closed.
ISIN
KYG2110P1000
Symbol
2877

China Shineway Pharmaceutica Target price 2026 - Analyst rating & recommendation

China Shineway Pharmaceutica Classifications & Recommendation

Hold
33%
Sell
67%

China Shineway Pharmaceutica Price Target

Target Price HK$8.67
Price HK$7.28
Potential
Number of Estimates 3
3 Analysts have issued a price target China Shineway Pharmaceutica 2027 . The average China Shineway Pharmaceutica target price is HK$8.67. This is higher than the current stock price. The highest price target is , the lowest is .
A rating was issued by 9 analysts: 0 Analysts recommend China Shineway Pharmaceutica to buy, 3 to hold and 6 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the China Shineway Pharmaceutica stock has an average upside potential 2027 of . Most analysts recommend the China Shineway Pharmaceutica stock at Sale.

Sales and Margin forecast 2026, 2027 & 2028

Create a premium account to unlock analyst estimates. Learn more

Select at least one metric to display the chart.


Dec '25 2026
Estimates
Revenue Billion HK$ ??? ???
??? ???
EBITDA Margin ??? ???
??? ???
Net Margin ??? ???
??? ???

3 Analysts have issued a sales forecast China Shineway Pharmaceutica 2026 . The average China Shineway Pharmaceutica sales estimate is

. This is than the revenue of the last 12 months(TTM). The highest sales forecast is , the lowest is .

This results in the following potential growth metrics:

Revenue Estimates

2025 HK$3.7b 17.01%
2026
2027
2028

3 China Shineway Pharmaceutica Analysts have issued a net profit forecast 2026. The average China Shineway Pharmaceutica net profit estimate is

. This is than the net profit for the last 12 months(TTM). The highest net profit forecast is , the lowest is .

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2025 HK$1.1b 13.08%
2026
2027
2028

Net Margin

2025 30.30% 36.26%
2026
2027
2028

Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 & 2028

Create a premium account to unlock analyst estimates. Learn more

Select at least one metric to display the chart.


Dec '25 2026
Estimates
Earnings Per Share HK$ ??? ???
??? ???
P/E ???
EV/Sales ???

3 Analysts have issued a China Shineway Pharmaceutica forecast for earnings per share. The average China Shineway Pharmaceutica EPS is

. This is than earnings per share in the financial year 2025. The highest EPS forecast is , the lowest is .

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2025 HK$1.48 12.98%
2026
2027
2028

P/E ratio

Current 5.82 12.28%
2026
2027
2028

Based on analysts' sales estimates for 2026, the China Shineway Pharmaceutica stock is valued at an EV/Sales of

and an P/S ratio of .

This results in the following potential growth metrics and future valuations:

EV/Sales

Current -0.97
2026
2027
2028

P/S ratio

Current
2026
2027
2028

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today